EN 
ES
PT
TH
DE
TR
FR
I-AQ ephephile
I-bi-functional glucose yegazi kanye nohlelo lokuqapha i-uric acid; Ukukhishwa okuzenzakalelayo kwe-strips; Kuvunyelwe i-ISO15197 2013; Ikhodi ehlakaniphile yokuhlolwa kwe-uric acid
Uhlolojikelele
Uhlelo Oluphephile lwe-AQ UG Igazi kanye nohlelo lokuqapha i-Uric Acid yakhelwe isilinganiso esilinganiswayo se-glucose ne-uric acid kumasampula amasha egazi aphelele nakamasampula egazi omzimba wonke. Uhlelo Oluphephile lwe-AQ UG Blood Glucose ne-Uric Acid Monitoring isetshenziswa ngaphandle komzimba kuphela (ukusetshenziswa kwe-vitro diagnostic) ukuzihlola nokusebenzisa ubuchwepheshe njengendlela yokusiza ekuphatheni ushukela kanye ne-hyperuricemia (HUA).
Ukucaciswa
| Umsebenzi wokuhlola | Igazi leglucose | I-Acid |
|---|---|---|
| indlela Test | FAD-GDH | I-Oxidized Ferrocene Derivative |
| Uhlobo lwesampula | I-peripheral capillary lonke igazi / i-venous lonke igazi | I-peripheral capillary lonke igazi / igazi eliphelele le-venous |
| Isampula yegazi | I-0.6µl | I-3µl |
| Ibanga lokuhlola | I-20-600mg / dL (1.1-33.3mmol / L) | I-3.0-20.0mg / dL I-181-1188 µmol / L） |
| Isikhathi sokuhlola | 5s | 25s |
| Memory | 500 lishona | 100 lishona |
| Imivimbo yangempela | 24 izinyanga | 12 izinyanga |
Evalu Ukuhlolwa kokusebenzisa komsebenzisi ushukela egazini:
| Imiphumela yokugxila kwe-glucose <100 mg / dL (<5.55mmol / l) | ||
|---|---|---|
| Ngaphakathi ± 5mg / dL (ngaphakathi ± 0.28mmol / l) | Ngaphakathi ± 10mg / dL (ngaphakathi ± 0.56mmol / l) | Ngaphakathi ± 15mg / dL (ngaphakathi ± 0.83mmol / l) |
| I-50% (14 / 28) | I-85.71% (24 / 28) | I-100% (28 / 28) |
| Imiphumela yokugxila kwe-glucose ≥ 100 mg / dL (≥5.55mmol / l) | ||
| Ngaphakathi ± 5% | Ngaphakathi ± 10% | Ngaphakathi ± 15% |
| I-55.56% (40 / 72) | I-90.28% （65 / 72) | I-97.22% (70 / 72) |
Evalu Ukuhlola ukusebenza komsebenzisi we-Uric acid:
| Imiphumela yokugxila kwe-uric acid <297μmol / L (5.0 mg / dL) | ||
|---|---|---|
| Ngaphakathi ± 14.9μmol / L (Ngaphakathi ± 0.3 mg / dL) | Ngaphakathi ± 29.7μmol / L (Ngaphakathi ± 0.5 mg / dL) | Ngaphakathi ± 59.4μmol / L (Ngaphakathi ± 1.0 mg / dL) |
| I-40.0% (6 / 15) | I-60.0% (9 / 15) | I-100% (15 / 15) |
| Imiphumela yokugxilwa kwe-uric acid≥ 297μmol / L (5.0 mg / dL) | ||
| Ngaphakathi ± 5% I-57.6% (49 / 85) | Ngaphakathi ± 10% I-94.1% （80 / 85) | Ngaphakathi ± 15% I-100% (85 / 85) |
Xhumana nathi